Share this Event
R&D is an essential investment for companies wanting to improve what they’re doing, but in New Zealand investment in R&D lags behind many of our counterparts on the world stage. The NZ Government has therefore committed to increasing New Zealand’s expenditure on R&D to 2% of GDP by 2027. To realise this ambition requires both the public and private sectors to raise their levels of R&D expenditure.
Join us at our upcoming TINShed: Tapping into New Zealand’s Innovation Ecosystem – A “How-To” Session on Leveraging Your R&D Efforts.
Our panel of experts will share their experience and discuss the tools that are available to NZ tech companies to enable the growth and success of their business.
Discussion points will include:
- How to make the most of the R&D tax incentive
- Leveraging R&D into commercial success
- Using IP to protect R&D from competitors and making innovation more attractive to investors and partners
- Funding vehicles available to innovative early-stage, high-growth companies
- How to access this funding and what support investors can offer
Date & Time:
Tuesday, 2 July 2019
Partner, James & Wells
Ceri is a founding partner of James & Wells and an outspoken champion of innovation. Ceri is often called on to provide companies with a high level overview of their business from an IP perspective, and develop innovation policies and IP strategies to fit the business objectives of the enterprise.
Dr Tim Benbow
Partner, R&D and Incentives, EY
Tim is a Partner in the R&D and Incentives team based in Auckland. He has more than eleven years’ experience providing R&D tax, R&D process and government grant advice to large and small companies across numerous sectors, but with specific focus on IT, manufacturing, food and agri-businesses.
Prior to EY, Tim spent five years working as a RTD scientist and analytical chemist, providing scientific consulting services to companies in the research, agricultural and environmental sectors.
Tim’s unique combination of R&D tax incentive, grant and deep scientific research experience enables him to effectively engage at all levels within a business and to deliver services in a highly efficient manner. Tim’s commercial understanding also means he is able to help business prioritise any R&D tax/grant opportunities within their broader commercial activities.
General Manager, LevelTwo
Imche is passionate about supporting New Zealand’s deep technology industries and bringing our tech to the world stage. She works with science and tech start-ups as the General Manager of LevelTwo, New Zealand’s home for deep tech ventures, and is an advocate for investing for the long term in companies that solve global environmental problems. Imche is a strong supporter of all facets of deep technology and has a background and particular interest in biotech. She sits on a number of investment committees and is a mentor to several young entrepreneurs.
Business Innovation Advisor, Callaghan Innovation
Andrew Clews is Callaghan Innovation’s principal Business Innovation Advisor supporting Med-Tech and Life Sciences companies and represents Callaghan Innovation as part of the Consortium for Medical Device Technologies (CMDT). As New Zealand’s innovation agency, Callaghan Innovation works with New Zealand businesses to develop and commercialise their new technology ideas.
Andrew joined Callaghan Innovation following more than 16 years in the US working in complex sectors as diverse as electromechanical devices and biotech/cleantech. He has a background in business internationalisation and the commercialisation of new technology, new products and new brands in complex categories.Andrew has held senior management and leadership team roles in a wide variety of organisations from major corporates to startups and IPO-focused growth companies.